Lind Global Fund II LP 13D and 13G filings for Constellation Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-21 4:52 pm Purchase | 2023-02-16 | 13G | Constellation Pharmaceuticals, Inc. CNST | Lind Global Fund II LP | 1,505,000 9.900% | 1,505,000 (New Position) | Filing |
| 2023-02-21 4:51 pm Purchase | 2023-02-17 | 13G | Constellation Pharmaceuticals, Inc. CNST | Lind Global Fund II LP | 1,018,518 6.200% | 1,018,518 (New Position) | Filing |